Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,019 | -7,009 | -3,811 | -12,155 | -10,800 |
| Depreciation Amortization | 19 | 11 | 5 | 23 | 17 |
| Accounts payable and accrued liabilities | -326 | 387 | 81 | -515 | 108 |
| Other Working Capital | 1,082 | 984 | 1,022 | 190 | 1,684 |
| Other Operating Activity | 2,282 | 217 | 277 | 2,581 | 3,246 |
| Operating Cash Flow | $-8,962 | $-5,409 | $-2,425 | $-9,876 | $-5,745 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,986 | -9,015 | 984 | -9,979 | -3,174 |
| PPE Investments | -43 | -30 | -17 | -9 | -9 |
| Other Investing Activity | 297 | 298 | 299 | 2,491 | 2,493 |
| Investing Cash Flow | $-8,732 | $-8,747 | $1,265 | $-7,497 | $-690 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,742 | 26,742 | 17 | 18,179 | 17,989 |
| Financing Cash Flow | $26,742 | $26,742 | $17 | $18,179 | $17,989 |
| Beginning Cash Position | 2,216 | 2,216 | 2,216 | 1,410 | 1,410 |
| End Cash Position | 11,264 | 14,802 | 1,073 | 2,216 | 12,963 |
| Net Cash Flow | $9,048 | $12,586 | $-1,144 | $806 | $11,553 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,962 | -5,409 | -2,425 | -9,876 | -5,745 |
| Capital Expenditure | -43 | -30 | -17 | -9 | -9 |
| Free Cash Flow | -9,005 | -5,439 | -2,442 | -9,885 | -5,755 |